Cargando…
Short term safety of coronavirus disease 2019 vaccines in patients with solid tumors receiving systemic therapy
BACKGROUND: There are currently three coronavirus disease 2019 (COVID-19) vaccines approved by the United States Food and Drug Administration to prevent coronavirus infection. However, robust data are unavailable on the adverse events of the vaccines in patients with solid tumor malignancies undergo...
Autores principales: | Cox, Ronald E, Parish, Marie, Oxencis, Carolyn, Mckenna, Edward, Thapa, Bicky, Chakrabarti, Sakti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346427/ https://www.ncbi.nlm.nih.gov/pubmed/36157156 http://dx.doi.org/10.5306/wjco.v13.i7.599 |
Ejemplares similares
-
Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study
por: Lei, Xue-Fen, et al.
Publicado: (2018) -
Impact of laparoscopic liver resection on bleeding complications in patients receiving antithrombotics
por: Fujikawa, Takahisa, et al.
Publicado: (2017) -
Role of endoscopic ultrasound in the characterization of solid pseudopapillary neoplasm of the pancreas
por: Pawlak, Katarzyna M, et al.
Publicado: (2023) -
Effect of overtime pancreaticoduodenectomy on the short-term prognosis of patients
por: Zhang, Jin-Zhu, et al.
Publicado: (2022) -
Risk factors and outcomes of delayed graft function in renal transplant recipients receiving a steroid sparing immunosuppression protocol
por: Willicombe, Michelle, et al.
Publicado: (2017)